Status:
COMPLETED
The Effect of Indomethacin in Monosymptomatic Enuresis Nocturnal
Lead Sponsor:
University of Aarhus
Conditions:
Enuresis
Eligibility:
All Genders
7-14 years
Phase:
PHASE4
Brief Summary
Monosymptomatic nocturnal enuresis, defined as the involuntary loss of urine during the night at an age where voluntary bladder control should have been attained and on the background of normal urinar...
Detailed Description
The "in-patient" phase is a comparative circadian study of three groups of participants and a non-placebo controlled study of the renal effects of indomethacin with special reference the renal handlin...
Eligibility Criteria
Inclusion
- Monosymptomatic enuresis nocturnal
- At least 3 nights with enuresis per week
- Incomplete response to dDAVP
Exclusion
- Daytime incontinence
- Urgency
- Frequency
- Other conditions that influence normal urine production
Key Trial Info
Start Date :
January 1 2003
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2009
Estimated Enrollment :
56 Patients enrolled
Trial Details
Trial ID
NCT00226122
Start Date
January 1 2003
End Date
December 1 2009
Last Update
June 25 2010
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Dept of Pediatrics, Aarhus University Hospital
Aarhus N, Jutland, Denmark, 8200